These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17214846)

  • 1. Novel host response therapeutic approaches to treat periodontal diseases.
    Kirkwood KL; Cirelli JA; Rogers JE; Giannobile WV
    Periodontol 2000; 2007; 43():294-315. PubMed ID: 17214846
    [No Abstract]   [Full Text] [Related]  

  • 2. Host-mediated resolution of inflammation in periodontal diseases.
    Kantarci A; Hasturk H; Van Dyke TE
    Periodontol 2000; 2006; 40():144-63. PubMed ID: 16398691
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for managing periodontal inflammation.
    Schonfeld SE
    J Calif Dent Assoc; 2010 Apr; 38(4):272-83. PubMed ID: 20509367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host modulation therapy with anti-inflammatory agents.
    Preshaw PM
    Periodontol 2000; 2018 Feb; 76(1):131-149. PubMed ID: 29193331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host modulation as a therapeutic strategy in the treatment of periodontal disease.
    Kornman KS
    Clin Infect Dis; 1999 Mar; 28(3):520-6. PubMed ID: 10194070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of new technologies to diagnose and treat periodontal disease. A look to the future.
    Williams RC; Beck JD; Offenbacher SN
    J Clin Periodontol; 1996 Mar; 23(3 Pt 2):299-305. PubMed ID: 8707994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypochlorous acid and taurine-N-monochloramine in periodontal diseases.
    Mainnemare A; Mégarbane B; Soueidan A; Daniel A; Chapple IL
    J Dent Res; 2004 Nov; 83(11):823-31. PubMed ID: 15505230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
    Lee HM; Ciancio SG; Tüter G; Ryan ME; Komaroff E; Golub LM
    J Periodontol; 2004 Mar; 75(3):453-63. PubMed ID: 15088884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.
    Gu Y; Lee HM; Sorsa T; Salminen A; Ryan ME; Slepian MJ; Golub LM
    Pharmacol Res; 2011 Dec; 64(6):573-9. PubMed ID: 21771657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats.
    Napimoga MH; Benatti BB; Lima FO; Alves PM; Campos AC; Pena-Dos-Santos DR; Severino FP; Cunha FQ; Guimarães FS
    Int Immunopharmacol; 2009 Feb; 9(2):216-22. PubMed ID: 19070683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using host response modifiers in the treatment of periodontal disease.
    Novak MJ; Donley TG
    Pract Proced Aesthet Dent; 2002; 14(9):suppl 3-10; quiz 11. PubMed ID: 12685424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the host response in the treatment of periodontitis.
    Golub LM; Ryan ME; Williams RC
    Dent Today; 1998 Oct; 17(10):102-6, 108-9. PubMed ID: 10752438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection.
    Trombone AP; Ferreira SB; Raimundo FM; de Moura KC; Avila-Campos MJ; Silva JS; Campanelli AP; De Franco M; Garlet GP
    J Periodontal Res; 2009 Aug; 44(4):443-51. PubMed ID: 18973535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anti-infective mechanical therapy on clinical parameters and cytokine levels in human peri-implant diseases.
    Duarte PM; de Mendonça AC; Máximo MB; Santos VR; Bastos MF; Nociti FH
    J Periodontol; 2009 Feb; 80(2):234-43. PubMed ID: 19186963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates in periodontal treatment: a review.
    Badran Z; Kraehenmann MA; Guicheux J; Soueidan A
    Oral Health Prev Dent; 2009; 7(1):3-12. PubMed ID: 19408809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications for host modulatory therapy.
    Ryan ME
    Compend Contin Educ Dent; 2002 Nov; 23(11A):1071-6, 1079-80, 1082. PubMed ID: 12789987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference with immune-cell-mediated bone resorption in periodontal disease.
    Han X; Kawai T; Taubman MA
    Periodontol 2000; 2007; 45():76-94. PubMed ID: 17850450
    [No Abstract]   [Full Text] [Related]  

  • 18. Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions.
    Honda T; Domon H; Okui T; Kajita K; Amanuma R; Yamazaki K
    Clin Exp Immunol; 2006 Apr; 144(1):35-40. PubMed ID: 16542362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging concepts in periodontal therapy.
    Greenwell H; Bissada NF
    Drugs; 2002; 62(18):2581-7. PubMed ID: 12465998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
    Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
    J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.